Purchase Order 75N91018P00611
Award Date 9/5/18
Potential Completion Date 9/4/19
Potential Value $11K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $19,428 on September 12, 2018, with an ultimate completion date of September 28, 2019. Work is performed at the awardee's location in Bethesda, Maryland. The order covers life science research instrumentation and related supplies on a firm fixed-price basis. No set-aside was used.</p>
- <p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $5,310.80 on August 28, 2017, with ultimate completion on July 16, 2018. The order is for life science research supplies and equipment sourced from Bio-Rad's Life Science Group Division. Place of performance is Bethesda, Maryland. No set-aside was used; the award carries firm fixed-price pricing on a full-and-open competitive basis.</p>
- <p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. on August 16, 2016, with a ceiling value of $3,657.02 and an ultimate completion date of September 16, 2017. The order is firm fixed price with no set-aside. Work is performed in Bethesda, Maryland. Bio-Rad supplied laboratory equipment and instrumentation to support the Institute's research operations.</p>
- <p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $4,729.00 on June 11, 2018, with an ultimate completion date of August 10, 2019. No set-aside was used. Performance takes place at Bethesda, Maryland. The order is for life science research equipment or supplies from Bio-Rad's Life Science Group Division on a firm fixed-price basis.</p>
- <p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $8,544.00 on November 8, 2017, with ultimate completion November 7, 2018. Performance takes place in Bethesda, Maryland. The order covers life science research instrumentation and related supplies on a firm fixed-price basis. No set-aside applies.</p>
- <p>The National Cancer Institute issued a purchase order to Bio-Rad Laboratories, Inc. for $7,500.00 on August 9, 2017, with ultimate completion by August 13, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The order is for life science research equipment or related supplies and services from Bio-Rad's Life Science Group Division.</p>
- The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. on May 30, 2018, valued at $5,604.00 for life science research equipment and supplies, with ultimate completion on May 31, 2019. The order carries firm fixed-price pricing with no set-aside. Performance takes place in Bethesda, Maryland. Bio-Rad Laboratories is a for-profit manufacturer of polymerase chain reaction systems, droplet digital PCR instruments, and related laboratory consumables and maintenance...
- <p>The National Cancer Institute issued a purchase order to Bio-Rad Laboratories, Inc. valued at $7,672.44 on August 9, 2016, with final completion scheduled for August 14, 2017. Work is performed at Bio-Rad's facility in Bethesda, Maryland. The order covers laboratory equipment, reagents, or consumables supplied on a firm fixed-price basis. No small business set-aside was applied.</p>
- <p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. valued at $7,832.00 on September 8, 2015, with performance completion by September 7, 2016. No set-aside was used. Work is performed at Bio-Rad's facility in Rodeo, California. The order procures life science research and laboratory equipment or supplies from Bio-Rad's Life Science Group Division under firm fixed-price terms.</p>
- <p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $5,282.75 on September 7, 2017, with completion by October 8, 2017. No set-aside applied. Place of performance is Bethesda, Maryland. The order is firm fixed price.</p>